Інгібування ксантиноксидази похідними піразолону, що містять фрагмент 4-(фуран-2-іл)бензойної кислоти

• Date: 2023
• Main Authors: Beiko, Alona V., Kobzar, Oleksandr L., Kachaeva, Maryna V., Pilyo, Stepan G., Tanchuk, Vsevolod Yu., Vovk, Andriy I.
• Format: Article
• Language: English
• Published: National University of Pharmacy 2023
• Subjects: ксантиноксидаза; інгібування; піразолони; бензойна кислота; молекулярний докінг; молекулярна динаміка
• Online Access: https://ophcj.nuph.edu.ua/article/view/298726
• Journal Title: Journal of Organic and Pharmaceutical Chemistry

The pyrazolone-based 4-(furan-2-yl)benzoic acids have been synthesized and studied as xanthine oxidase inhibitors. This enzyme is one of the therapeutic targets for the treatment of hyperuricemia and related diseases. The compounds studied have found to exhibit low micromolar IC50 values relative to the enzyme in vitro, depending on substituents in position 3 of the pyrazolone ring. However, the inhibitory effects observed are reduced in the presence of bovine serum albumin or Tween-80. Among the pyrazolone derivatives synthesized, 4-(5-((3-methyl-5-oxo-1-phenyl-1,5-dihydro-4H-pyrazol-4-ylidene)methyl)furan-2-yl)benzoic acid has been found to be the most potent inhibitor of xanthine oxidase. Kinetic results have shown that this compound is a mixed-type inhibitor with higher affinity to the free enzyme than to the enzyme-substrate complex. The results of the molecular docking and molecular dynamics show that the carboxylic group of the inhibitor can form a salt bridge with Arg880 and a hydrogen bond with Thr1010. These interactions can be key factors in the enzyme-inhibitor complex stabilization.